3 - Red Flags, Clinical Presentation and Diagnostic Algorithm for Cardiac ATTR | UCA 2023
The Institute for Future Health held a hybrid conference on January 14th, 2023. The focus was on expanding the knowledge of cardiac amyloidosis amongst Arizona clinicians. This event was one of the first exclusively dedicated to cardiac amyloidosis for local physicians across multiple healthcare professions. Cardiac amyloidosis is a disease of protein misfolding that leads to congestive heart failure and disabling neuropathy. Cardiac amyloidosis can be caused by transthyretin or light-chain amyloidosis. The pace of knowledge in this field is greatly accelerating, and it is important for clinicians, nurses, research scientists, and patients to be aware of new developments. Learn more @ theifh.org *This activity is supported by an independent medical educational grant from Pfizer, Inc.
4 - Epidemiology, Health Equity, Population Screening in ATTR CA | UCA 2023
ATTR Cardiac Amyloidosis
Webinar « Cardiac Amyloidosis: All you need to know »
Cardiac Sarcoidosis
New MRI methods and preclinical models to assess the brain tumor microenvironment | Webinar
Emerging strategies in the management of ATTR amyloidosis
What's new and exciting in ATTR cardiac amyloidosis in 2024
Red Flags In physical therapy
Multimodality Imaging in Cardiac Amyloidosis, Dr. Marianna Fontana
Cardiomyopathy Conference 2020 - Restrictive Cardiomyopathy (RCM) - Professor Perry Elliott
Post-Cardiac Arrest Syndrome by A. de Caen, A. Olszewski, L. DelSignore | OPENPediatrics
Sospecha clínica en amiloidosis cardiaca
ERN GUARD-Heart Educational Video: Fabry's Cardiomyopathy
CCC 2019: ABCD OF ATTR AMYLOIDOSIS - A PRACTICAL APPROACH
Cardiac Evaluation- RED FLAGS in Primary Care
Q&A Session 1: Patient Questions about AL Amyloidosis
Dan - AL Amyloidosis Patient
She Was Trying to Cut It With Scissors and The Grass Was Taller Than My Mowers
Cleveland Conference 2018: Cardiac Sarcoidosis - Christine Jellis
